Nizam's Institute of Medical Sciences is a public hospital located in Hyderabad, Telangana, India and is named after its founder – the 7th Nizam of Hyderabad– and was inaugurated by Princess Durreshehvar It is an Institute under State Legislature Act under the Act of Andhra Pradesh State Legislature.

During the past decade, Nizams Institute of Medical Sciences conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 10 clinical trials were completed, i.e. on average, 47.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nizams Institute of Medical Sciences" #1 sponsor was "Boehringer Ingelheim" with 5 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Fungal Infection Study Forum" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Idorsia Pharmaceuticals Ltd." with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nizams Institute of Medical Sciences" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "University of Oxford" with 2 trials as a collaborator, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 1 trials as a collaborator, "Ankara University" with 1 trials as a collaborator and "Australasian Gastro-Intestinal Trials Group" with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Nizams Institute of Medical Sciences" are "Mycoses" (3 trials), "Anemia" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Dyslipidemia" (2 trials) and "Acute Stroke" (1 trials). Many other conditions were trialed in "Nizams Institute of Medical Sciences" in a lesser frequency.

Most popular intervention types in "Nizams Institute of Medical Sciences" are "Drug" (40 trials), "Other" (4 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "placebo" (4 trials), "Filgotinib" (2 trials), "Metformin" (2 trials) and "Nintedanib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Nizams Institute of Medical Sciences" are 45 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Nizams Institute of Medical Sciences". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Nizams Institute of Medical Sciences, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Nizams Institute of Medical Sciences, 2 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".